Recommended

New webinar with Fujifilm: Monocyte activation test (MAT): Insight into examining regulations and markets prospects
New webinar: The path to optimisation in pharmaceutical microbiology
Join our webinar: An alternative medium to support sterility testing using the Growth Direct® Rapid Sterility System
Discover more in our new application note: validating recombinant cascade reagents in 3 simple steps
Whitepaper

Synthesis and Route Design to Tackle API Complexity

These longer synthetic pathways present challenges for process chemists hoping to achieve an efficient API manufacturing process.

Small molecule active pharmaceutical ingredients (APIs) continue to grow more complex. As a result, API syntheses are growing longer and, at times, undermining drug sponsors’ speed-to-clinic. These longer synthetic pathways present challenges for process chemists hoping to achieve an efficient API manufacturing process, due to factors such as elaborate raw material needs and supply chain obstacles.

These compounding layers can delay start times and extend preclinical development. To help mitigate these issues for sponsors, Lonza Small Molecules has partnered with Elsevier Information Systems to leverage a synthesis planning and route scouting solution that combines Lonza’s intellectual property (IP) with Elsevier’s AI-enabled route design technology – Reaxys predictive retrosynthesis.

Download the whitepaper to learn more about using synthesis and route design technology to approach API complexity.